— Know what they know.
Not Investment Advice

SSKN OTC

STRATA Skin Sciences, Inc.
1W: +0.0% 1M: +0.0% 3M: -96.2% YTD: -99.6% 1Y: -99.7% 3Y: -99.9% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 56 · $23251 mcap · 2M float · 0.529% daily turnover · Short 44% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-2.65
Volume4,885
Avg Volume11,564
Beta-0.05
Dividend—
Analyst Ratings
5 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOErica Jordan
Employees114
SectorHealthcare
IndustryMedical - Devices
IPO Date2005-10-27
5 Walnut Grove Drive
Horsham, PA 19044
US
215 619 3200
About STRATA Skin Sciences, Inc.

STRATA Skin Sciences, Inc. is an innovative medical technology enterprise dedicated to the development, commercialization, and marketing of advanced products specifically designed for treating a range of dermatologic conditions. The company operates through two main divisions: Dermatology Recurring Procedures and Dermatology Procedures Equipment. With a substantial global footprint, STRATA Skin Sciences distributes its solutions across the United States, Europe, the Middle East, Asia, Australia, South Africa, and both Central and South America. Its notable product portfolio includes the XTRAC and Pharos excimer laser systems, VTRAC lamp systems, and TheraClear treatment solutions. These technologies are instrumental in addressing common skin ailments such as psoriasis, vitiligo, and acne, among others. Domestically, the company engages directly with physicians for product distribution, while leveraging a network of international distributors to reach markets beyond the U.S. Established in 1989 and headquartered in Horsham, Pennsylvania, the company adopted its current name, STRATA Skin Sciences, Inc., in January 2016, having previously operated as MELA Sciences, Inc.

Recent Insider Trades

NameTypeSharesPriceDate
Rubinstein Samuel P-Purchase 2,832 $1.41 2025-11-18
Rubinstein Samuel P-Purchase 2,168 $1.40 2025-11-18
Rubinstein Samuel S-Sale 5,500 $1.32 2025-11-17
Rubinstein Samuel S-Sale 7,200 $1.34 2025-11-17
Rubinstein Samuel S-Sale 1,394 $1.36 2025-11-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms